What are the major opportunities in the Immunotoxin market? What are the strategies for the Immunotoxin market?

For detailed insights on the major opportunities and strategies in the Immunotoxin market, Read More

How does the Immunotoxin market relate to the overall economy and other similar markets?

For detailed insights on Immunotoxin's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Immunotoxin market growth? SWOT analysis of the Immunotoxin market.

For detailed insights on the key dynamics influencing the Immunotoxin market growth and SWOT analysis of the Immunotoxin industry, Read More

Immunotoxin Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Immunotoxin Market Report 2026

Name: Immunotoxin Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Anthrax Based Toxins, Diphtheria Toxin (DT) And Derivatives, Pseudomonas Exotoxin (PE) And Derivatives, Ribosome Inactivating Proteins Based Immunotoxins, Ribonucleases-Based Immunotoxins, Other Types), By Application (Solid Tumors, Leukemias, Other Applications), By End User (Hospitals And Clinics, Cancer And Radiation Therapy Centers, Research Labs, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Immunotoxin Market Overview

• Immunotoxin market size has reached to $66 billion in 2025

• Expected to grow to $96.77 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Impact of Increasing Breast Cancer Incidence on the Immunotoxin Market

• Market Trend: FDA Approves First ADC For Metastatic Or Recurrent Cervical Cancer

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Immunotoxin Market?

Immunotoxins are bioengineered proteins that combine an antibody or antibody fragment with a toxin to selectively target and kill specific cells, such as cancer cells. The antibody portion of the immunotoxin binds to a specific antigen on the surface of the target cell, delivering the toxin directly to the cell. Immunotoxins are designed to spare healthy cells and tissues, minimizing side effects compared to traditional chemotherapy.

The main types of immunotoxins include anthrax-based toxins, diphtheria toxin (DT) and derivatives, pseudomonas exotoxin (PE) and derivatives, ribosome-inactivating proteins-based immunotoxins, ribonucleases-based immunotoxins, and others. Anthrax-based toxins are substances developed by bacteria that cause anthrax, a serious illness. They are used in various applications, such as solid tumors, leukemias, and others, by several end users, including hospitals and clinics, cancer and radiation therapy centers, research labs, and others.

Immunotoxin Market Global Report 2026 Market Report bar graph

What Is The Immunotoxin Market Size and Share 2026?

The immunotoxin market size has grown strongly in recent years. It will grow from $66 billion in 2025 to $71.71 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to early success of antibody-toxin conjugates in cancer research, advancements in monoclonal antibody engineering, unmet need for targeted cancer therapies, expansion of oncology-focused research laboratories, increased understanding of tumor-specific antigens.

What Is The Immunotoxin Market Growth Forecast?

The immunotoxin market size is expected to see strong growth in the next few years. It will grow to $96.77 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing demand for precision oncology treatments, expansion of immunotherapy pipelines, increasing investment in biologics-based cancer drugs, rising prevalence of treatment-resistant cancers, continued innovation in protein engineering technologies. Major trends in the forecast period include rising development of target-specific immunotoxins for cancer therapy, growing focus on reducing off-target toxicity and immunogenicity, increasing use of immunotoxins in hematological malignancies, expansion of clinical research in next-generation immunotoxin constructs, continued exploration of combination immunotoxin therapies.

Book your 30 minutes free consultation with our research experts

Global Immunotoxin Market Segmentation

1) By Type: Anthrax Based Toxins, Diphtheria Toxin (DT) And Derivatives, Pseudomonas Exotoxin (PE) And Derivatives, Ribosome Inactivating Proteins Based Immunotoxins, Ribonucleases-Based Immunotoxins, Other Types

2) By Application: Solid Tumors, Leukemias, Other Applications

3) By End User: Hospitals And Clinics, Cancer And Radiation Therapy Centers, Research Labs, Other End-Users

Subsegments:

1) By Anthrax-Based Toxins: Anthrax Lethal Toxin, Anthrax Protective Antigen

2) By Diphtheria Toxin (DT) And Derivatives: Diphtheria Toxin, DT Fragment-Based Immunotoxins

3) By Pseudomonas Exotoxin (PE) And Derivatives: PE38-Based Immunotoxins, PE-Based Fusion Proteins

4) By Ribosome Inactivating Proteins-Based Immunotoxins: Ricin-Based Immunotoxins, Gelonin-Based Immunotoxins

5) By Ribonucleases-Based Immunotoxins: Onconase-Based Immunotoxins, Binase-Based Immunotoxins

6) By Other Types: Shiga Toxin-Based Immunotoxins, Other Toxin-Based Immunotoxins

What Is The Driver Of The Immunotoxin Market?

The increasing incidence of breast cancer is expected to propel the growth of the immunotoxin market going forward. Breast cancer refers to a malignant tumor that develops in the cells of the breast, most commonly in the ducts or lobules. The incidence of breast cancer is rising due to improved screening programs, lifestyle-related risk factors, and increasing life expectancy. The immunotoxin market supports breast cancer treatment by providing targeted therapies that selectively kill cancer cells while minimizing damage to healthy tissue, thereby reducing side effects compared to traditional chemotherapy. For instance, in January 2025, according to the National Breast Cancer Foundation, a US-based organization, one in every eight women in the United States will be diagnosed with breast cancer during her lifetime. In 2024, approximately 310,720 women and 2,800 men are expected to be diagnosed with invasive breast cancer. Therefore, the increasing incidence of breast cancer is driving the growth of the immunotoxin industry.

Key Players In The Global Immunotoxin Market

Major companies operating in the immunotoxin market are ImmunoGen Inc., Molecular Templates Inc., Mersana Therapeutics, Seagen Inc., MacroGenics Inc., Sutro Biopharma Inc., Celldex Therapeutics, CytImmune Sciences Inc., Pfizer Inc., Roche Holding AG, AbbVie Inc., Bristol Myers Squibb, AstraZeneca plc, Merck KGaA, BioNTech SE, Ipsen Pharma, Innate Pharma Inc., GenScript, Thermo Fisher Scientific Inc., Enzo Life Sciences Inc.

Global Immunotoxin Market Trends and Insights

Major companies operating in the immunotoxin market are focusing on developing advanced antibody-drug conjugates (ADCs) to enhance the specificity and effectiveness of cancer treatment while reducing harm to healthy tissues. ADCs refer to targeted biopharmaceutical therapies composed of a monoclonal antibody linked to a cytotoxic drug, enabling precise delivery of the toxic payload to cancer cells that express a specific antigen and improving therapeutic outcomes compared to conventional chemotherapy. For instance, in April 2024, Pfizer Inc., a US-based pharmaceutical company, and Genmab A/S, a Denmark-based biotechnology company, received full U.S. FDA approval for TIVDAK, an antibody-drug conjugate designed for patients with metastatic or recurrent cervical cancer, featuring a monomethyl auristatin E payload that disrupts microtubules to induce cancer-cell death and demonstrating statistically significant improvements in overall survival, establishing it as a promising targeted treatment option for advanced cervical cancer.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Immunotoxin Market?

In February 2024, AbbVie, a US-based biopharmaceutical company, acquired ImmunoGen Inc. for an undisclosed amount. This acquisition strengthens AbbVie’s oncology portfolio by integrating ImmunoGen’s innovative antibody-drug conjugate (ADC) technology to advance the development of targeted cancer therapies. It further enhances AbbVie’s strategic position in next-generation oncology treatments by expanding its pipeline with clinically validated ADC assets. ImmunoGen Inc. is a US-based biotechnology company that develops immunotoxins.

Regional Insights

North America was the largest region in the immunotoxin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Immunotoxin Market?

The immunotoxin market consists of sales of linker molecules, expression systems, antibody or antibody fragments, and cytotoxic agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Immunotoxin Market Report 2026?

The immunotoxin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immunotoxin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Immunotoxin Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$71.71 billion
Revenue Forecast In 2035	$96.77 billion
Growth Rate	CAGR of 8.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	ImmunoGen Inc., Molecular Templates Inc., Mersana Therapeutics, Seagen Inc., MacroGenics Inc., Sutro Biopharma Inc., Celldex Therapeutics, CytImmune Sciences Inc., Pfizer Inc., Roche Holding AG, AbbVie Inc., Bristol Myers Squibb, AstraZeneca plc, Merck K
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Immunotoxin Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Immunotoxin Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Immunotoxin Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Immunotoxin Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Development Of Target-Specific Immunotoxins For Cancer Therapy

4.2.2 Growing Focus On Reducing Off-Target Toxicity And Immunogenicity

4.2.3 Increasing Use Of Immunotoxins In Hematological Malignancies

4.2.4 Expansion Of Clinical Research In Next-Generation Immunotoxin Constructs

4.2.5 Continued Exploration Of Combination Immunotoxin Therapies

5. Immunotoxin Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Cancer And Radiation Therapy Centers

5.3 Research Laboratories

5.4 Academic And Research Institutes

5.5 Biopharmaceutical Companies

6. Immunotoxin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunotoxin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Immunotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Immunotoxin Market Size, Comparisons And Growth Rate Analysis

7.3. Global Immunotoxin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Immunotoxin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunotoxin Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunotoxin Market Segmentation

9.1. Global Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anthrax Based Toxins, Diphtheria Toxin (DT) And Derivatives, Pseudomonas Exotoxin (PE) And Derivatives, Ribosome Inactivating Proteins Based Immunotoxins, Ribonucleases-Based Immunotoxins, Other Types

9.2. Global Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Solid Tumors, Leukemias, Other Applications

9.3. Global Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Cancer And Radiation Therapy Centers, Research Labs, Other End-Users

9.4. Global Immunotoxin Market, Sub-Segmentation Of Anthrax Based Toxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anthrax Lethal Toxin, Anthrax Protective Antigen

9.5. Global Immunotoxin Market, Sub-Segmentation Of Diphtheria Toxin (DT) And Derivatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diphtheria Toxin, DT Fragment-Based Immunotoxins

9.6. Global Immunotoxin Market, Sub-Segmentation Of Pseudomonas Exotoxin (PE) And Derivatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PE38-Based Immunotoxins, PE-Based Fusion Proteins

9.7. Global Immunotoxin Market, Sub-Segmentation Of Ribosome Inactivating Proteins Based Immunotoxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ricin-Based Immunotoxins, Gelonin-Based Immunotoxins

9.8. Global Immunotoxin Market, Sub-Segmentation Of Ribonucleases-Based Immunotoxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Onconase-Based Immunotoxins, Binase-Based Immunotoxins

9.9. Global Immunotoxin Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Shiga Toxin-Based Immunotoxins, Other Toxin-Based Immunotoxins

10. Immunotoxin Market Regional And Country Analysis

10.1. Global Immunotoxin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Immunotoxin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunotoxin Market

11.1. Asia-Pacific Immunotoxin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunotoxin Market

12.1. China Immunotoxin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunotoxin Market

13.1. India Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunotoxin Market

14.1. Japan Immunotoxin Market Overview

14.2. Japan Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunotoxin Market

15.1. Australia Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunotoxin Market

16.1. Indonesia Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunotoxin Market

17.1. South Korea Immunotoxin Market Overview

17.2. South Korea Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunotoxin Market

18.1. Taiwan Immunotoxin Market Overview

18.2. Taiwan Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunotoxin Market

19.1. South East Asia Immunotoxin Market Overview

19.2. South East Asia Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunotoxin Market

20.1. Western Europe Immunotoxin Market Overview

20.2. Western Europe Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunotoxin Market

21.1. UK Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunotoxin Market

22.1. Germany Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunotoxin Market

23.1. France Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunotoxin Market

24.1. Italy Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunotoxin Market

25.1. Spain Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunotoxin Market

26.1. Eastern Europe Immunotoxin Market Overview

26.2. Eastern Europe Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunotoxin Market

27.1. Russia Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunotoxin Market

28.1. North America Immunotoxin Market Overview

28.2. North America Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunotoxin Market

29.1. USA Immunotoxin Market Overview

29.2. USA Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunotoxin Market

30.1. Canada Immunotoxin Market Overview

30.2. Canada Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunotoxin Market

31.1. South America Immunotoxin Market Overview

31.2. South America Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunotoxin Market

32.1. Brazil Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunotoxin Market

33.1. Middle East Immunotoxin Market Overview

33.2. Middle East Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunotoxin Market

34.1. Africa Immunotoxin Market Overview

34.2. Africa Immunotoxin Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunotoxin Market Regulatory and Investment Landscape

36. Immunotoxin Market Competitive Landscape And Company Profiles

36.1. Immunotoxin Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Immunotoxin Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Immunotoxin Market Company Profiles

36.3.1. ImmunoGen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Molecular Templates Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Mersana Therapeutics Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Seagen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. MacroGenics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Immunotoxin Market Other Major And Innovative Companies

Sutro Biopharma Inc., Celldex Therapeutics, CytImmune Sciences Inc., Pfizer Inc., Roche Holding AG, AbbVie Inc., Bristol Myers Squibb, AstraZeneca plc, Merck KGaA, BioNTech SE, Ipsen Pharma, Innate Pharma Inc., GenScript, Thermo Fisher Scientific Inc., Enzo Life Sciences Inc.

38. Global Immunotoxin Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunotoxin Market

40. Immunotoxin Market High Potential Countries, Segments and Strategies

40.1 Immunotoxin Market In 2030 - Countries Offering Most New Opportunities

40.2 Immunotoxin Market In 2030 - Segments Offering Most New Opportunities

40.3 Immunotoxin Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Immunotoxin Market, Overview Of Key Products - Product Examples

Table 2: Global Immunotoxin Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Immunotoxin Market, Supply Chain Analysis

Table 4: Global Immunotoxin Market, Major Raw Material Providers

Table 5: Global Immunotoxin Market, Major Resource Providers

Table 6: Global Immunotoxin Market, Major Manufacturers (Suppliers)

Table 7: Global Immunotoxin Market, Major Distributors And Channel Partners

Table 8: Global Immunotoxin Market, Key Technologies & Future Trends

Table 9: Global Immunotoxin Market, Major Trends

Table 10: Global Immunotoxin Market, Major End Users

Table 11: Global Immunotoxin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Immunotoxin Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Immunotoxin Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Immunotoxin Market - TAM, US$ Billion, 2025

Table 15: Global Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Immunotoxin Market, Sub-Segmentation Of Anthrax Based Toxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Immunotoxin Market, Sub-Segmentation Of Diphtheria Toxin (DT) And Derivatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Immunotoxin Market, Sub-Segmentation Of Pseudomonas Exotoxin (PE) And Derivatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Immunotoxin Market, Sub-Segmentation Of Ribosome Inactivating Proteins Based Immunotoxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Immunotoxin Market, Sub-Segmentation Of Ribonucleases-Based Immunotoxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Immunotoxin Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Immunotoxin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Immunotoxin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Immunotoxin Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Immunotoxin Market - Company Scoring Matrix

Table 100: ImmunoGen Inc. Financial Performance

Table 101: Molecular Templates Inc. Financial Performance

Table 102: Mersana Therapeutics Financial Performance

Table 103: Seagen Inc. Financial Performance

Table 104: MacroGenics Inc. Financial Performance

Table 105: Global Immunotoxin Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Immunotoxin Market, Competitive Dashboard

Table 107: Global Immunotoxin Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Immunotoxin Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 109: Global, Immunotoxin Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 110: Global, Immunotoxin Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Immunotoxin Market, Overview Of Key Products - Product Examples

Figure 2: Global Immunotoxin Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Immunotoxin Market, Supply Chain Analysis

Figure 4: Global Immunotoxin Market, Major Raw Material Providers

Figure 5: Global Immunotoxin Market, Major Resource Providers

Figure 6: Global Immunotoxin Market, Major Manufacturers (Suppliers)

Figure 7: Global Immunotoxin Market, Major Distributors And Channel Partners

Figure 8: Global Immunotoxin Market, Key Technologies & Future Trends

Figure 9: Global Immunotoxin Market, Major Trends

Figure 10: Global Immunotoxin Market, Major End Users

Figure 11: Global Immunotoxin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Immunotoxin Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Immunotoxin Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Immunotoxin Market - TAM, US$ Billion, 2025

Figure 15: Global Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Immunotoxin Market, Sub-Segmentation Of Anthrax Based Toxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Immunotoxin Market, Sub-Segmentation Of Diphtheria Toxin (DT) And Derivatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Immunotoxin Market, Sub-Segmentation Of Pseudomonas Exotoxin (PE) And Derivatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Immunotoxin Market, Sub-Segmentation Of Ribosome Inactivating Proteins Based Immunotoxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Immunotoxin Market, Sub-Segmentation Of Ribonucleases-Based Immunotoxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Immunotoxin Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Immunotoxin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Immunotoxin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Immunotoxin Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Immunotoxin Market - Company Scoring Matrix

Figure 100: ImmunoGen Inc. Financial Performance

Figure 101: Molecular Templates Inc. Financial Performance

Figure 102: Mersana Therapeutics Financial Performance

Figure 103: Seagen Inc. Financial Performance

Figure 104: MacroGenics Inc. Financial Performance

Figure 105: Global Immunotoxin Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Immunotoxin Market, Competitive Dashboard

Figure 107: Global Immunotoxin Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Immunotoxin Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 109: Global, Immunotoxin Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 110: Global, Immunotoxin Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Immunoglobulins Market Report 2026 - Global Outlook – By Product (IGG, IGA, IGM, IGE, IGD), By Mode Of Delivery (Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery ), By Application (Hypogammaglobulinemia, Chron...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Neurotoxin Market Report 2026 - Global Outlook – By Product Type (Botox, Dysport, Xeomin, Other Products), By Application (Therapeutic, Aesthetic), By End User (Hospitals, Specialty Clinics, Dermatology Clinics, Other En...

Immunomodulator Market Report 2026 - Global Outlook – By Product Type (Immunosuppressants, Immunostimulants, Other Product Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distr...

Botulinum Toxin Market Report 2026 - Global Outlook – By Type (Botulinum Toxin Type A, Botulinum Toxin Type B), By Application (Therapeutics, Aesthetics), By End User (Hospitals, Specialty Clinics, Dermatology Clinics, O...

Immunohematology Market Report 2026 - Global Outlook – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PC...

Endotoxin Testing Market Report 2026 - Global Outlook – By Test Type (LAL (Limulus Amebocyte Lysate) Test, Chromogenic Tests, Turbidimetric Tests, Gel Clot Tests, MAT Test, Rabbit Pyrogen Test, Recombinant Factor C (rFC)...

Frequently Asked Questions

How big is the Immunotoxin Market?

The Immunotoxin market was valued at $66 billion in 2025, increased to $71.71 billion in 2026, and is projected to reach $96.77 billion by 2030. request a sample here

What is the Immunotoxin market growth?

The global Immunotoxin market is expected to grow at a CAGR of 7.8% from 2026 to 2035 to reach $96.77 billion by 2035. request a sample here

Who are the key players in Immunotoxin market?

Some Key Players in the Immunotoxin market Include, ImmunoGen Inc., Molecular Templates Inc., Mersana Therapeutics, Seagen Inc., MacroGenics Inc., Sutro Biopharma Inc., Celldex Therapeutics, CytImmune Sciences Inc., Pfizer Inc., Roche Holding AG, AbbVie Inc., Bristol Myers Squibb, AstraZeneca plc, Merck KGaA, BioNTech SE, Ipsen Pharma, Innate Pharma Inc., GenScript, Thermo Fisher Scientific Inc., Enzo Life Sciences Inc. . request a sample here

What is the anticipated growth trend for the Immunotoxin market?

Major trend in this market includes: FDA Approves First ADC For Metastatic Or Recurrent Cervical Cancer. For further insights on this market. request a sample here

Which region has the most growth potential in the Immunotoxin market?

North America was the largest region in the immunotoxin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunotoxin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Immunotoxin Market Report 2026 market?

Major companies operating in the Immunotoxin Market Report 2026 market are Major companies operating in the immunotoxin market are ImmunoGen Inc., Molecular Templates Inc., Mersana Therapeutics, Seagen Inc., MacroGenics Inc., Sutro Biopharma Inc., Cell request a sample here.